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Abstract
Significance: p62/SQSTM1 is a multifunctional scaffolding protein involved in the regulation of various signaling
pathways as well as autophagy. In particular, p62/SQSTM1 serves as an essential adaptor to identify and deliver
specific organelles and protein aggregates to autophagosomes for degradation, a process known as selective autophagy.
Critical Issues: With the emergence of autophagy as a critical process in cellular metabolism and the devel-
opment of cardiometabolic diseases, it is increasingly important to understand p62’s role in the integration of
signaling and autophagic pathways.
Recent Advances: This review first discusses the features that make p62/SQSTM1 an ideal chaperone in inte-
grating signaling pathways with autophagy and details the current understanding of its diverse roles in selective
autophagy processes. Distinct and overlapping roles of other chaperones with similar functions are then discussed
in the context of p62/SQSTM1. Finally, the recent literature focusing on p62 and selective autophagy in me-
tabolism and the spectrum of cardiometabolic diseases including atherosclerosis, fatty liver disease, and obesity is
evaluated.
Future Directions: A comprehensive understanding of the nuanced roles p62/SQSTM1 plays in mediating distinct
autophagy pathways would provide new insights into the mechanisms of this critical degradative pathway. This
will, in turn, facilitate our understanding of cardiovascular and cardiometabolic disease pathology and the de-
velopment of novel autophagy-modulating therapeutic strategies. Antioxid. Redox Signal. 31, 458–471.
Keywords: p62/SQSTM1, selective autophagy, cardiometabolic disease, cardiovascular disease, atherosclerosis,
fatty liver disease
The Structure of p62/SQSTM1
P62/SQSTM1 (hereafter called p62) contains a seriesof distinct domains that act in concert with binding
partners to integrate and modulate a variety of cellular pro-
cesses. As we describe hereunder, prominent p62 domains
include the N-terminus PB1 (Phox/Bem1p), followed by
the ZZ-type zinc finger (ZZ) domain, the tumor necrosis
factor receptor-associated factor 6 (TRAF6)-binding se-
quence (TBS), the microtubule-associated protein light
chain 3 (LC3)-interacting region (LIR), the Kelch-like ECH-
associated protein 1 (Keap1)-interacting region (KIR), and the
C-terminal ubiquitin-associated (UBA) domain (Fig. 1).
The PB1 domain of p62 can bind atypical protein kinase C
(aPKC) and activate aPKC-mediated nuclear factor kappa B
(NF-jB) signaling (89, 90) to affect inflammatory responses.
The PB1 domain also interacts and negatively regulates ex-
tracellular signal-regulated kinase 1 (ERK1), with crucial
roles during adipogenesis and obesity (58). Furthermore, PB1
domain is required for p62 oligomerization and for binding
with other PB1-containing protein, contributing to its role as
a scaffolding protein (72).
The ZZ domain of p62 interacts with receptor-interacting
protein 1 (RIP1) and serves to recruit aPKC to the tumor
necrosis factor a (TNFa) signaling cascade, stimulating
NF-jB and its downstream activation of the inflammatory
1Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
2Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri.
3John Cochran VA Medical Center, St. Louis, Missouri.
ANTIOXIDANTS & REDOX SIGNALING
Volume 31, Number 6, 2019

















































response (90). In addition, a p38-binding sequence next to the
ZZ domain can activate p38 mitogen-activated protein kinase
(MAPK) and its targets, PPARc coactivator-1a (PGC1a) and
uncoupling protein 1 (UCP1), affecting mitochondrial function
and brown adipose tissue (BAT) thermogenesis (74).
The TBS has been identified as TRAF6 binding motif. The
p62–TRAF6 interaction in conjunction with the binding of
aPKC through the PB1 domain fosters nerve growth factor
(NGF) signaling (111), receptor activator of NF-jB (RANK)-
induced NF-jB activation in osteoclastogenesis and bone
remodeling (19), and Ras-induced tumorigenesis (18, 70).
The region between the ZZ and TBS domains is important
for the interaction of p62 and raptor, a core subunit of
mammalian target of rapamycin (mTOR) complex 1
(mTORC1) and crucial for mTOR activation (17) and its
inhibitory effects on autophagy (71).
Although the p62–Raptor interaction is clearly important
for p62’s effects in metabolism, a more direct role for p62 in
autophagy is its direct binding to the autophagosome coat
protein LC3/Atg8 and other mammalian Atg8 homologues
through the LIR motif (82). Not only is this interaction crit-
ical for delivery of cargo to autophagosomes, but it also
potentially serves an important role in the formation of au-
tophagosomes themselves (27, 42).
Another well-characterized p62 domain is the KIR motif
wherein direct binding of p62 with Keap1 induces its au-
tophagic degradation (56), thereby neutralizing Keap1’s in-
hibitory effects on the nuclear factor erythroid 2-related
factor 2 (NRF2), a transcription factor responsive to oxida-
tive stress (36). Interestingly, the p62–Keap1 interaction is
dependent on p62 oligomerization via its PB1 domain (36),
demonstrating the importance of multiple p62 domains in its
modulation of signaling pathways.
Finally, The C-terminal UBA domain of p62 is known to
bind and sequester ubiquitinated proteins, primarily targeting
them for autophagic degradation via the LC3-interacting
motif already mentioned (34, 63, 73). More nuanced regu-
lation also exists at the UBA domain. For example, the
phosphorylation of serine 403 (S403) by TANK binding ki-
nase 1 (TBK1) and casein kinase 2 (CK2) or the ubiquiti-
nation of lysine 420 (K420) by Keap1/cullin3, both of which
are located in the UBA, modulates its binding affinity for
polyubiquitinated chains and subsequent autophagic degra-
dation (59, 68, 85). Furthermore, the UBA has also been
shown to bind cullin3-mediated caspase-8 polyubiquitina-
tion, thus controlling apoptotic signaling (39).
p62 As a Chaperone for Selective Autophagy
Autophagy is the predominant mechanism for delivering
protein aggregates and long-lived/damaged organelles to
lysosomes for degradation. In addition to playing the criti-
cal role of eliminating unwanted or damaged cellular cargo
and thus protecting the cell from intracellular stressors,
FIG. 1. The structural domain organization, interacting partners, and functions of p62. p62 is a multidomain protein with
roles in the regulation of numerous signaling pathways through distinct binding partners. Depicted are the N-terminal PB1
domain, followed by the ZZ domain, the p38-binding sequence, the TRAF6 binding sequence, LIR, KIR, and a C-terminal UBA
domain. aPKC, atypical protein kinase C; BAT, brown adipose tissue; ERK1, extracellular signal-regulated kinase 1; Keap1, Kelch-
like ECH-associated protein 1; KIR, Keap1-interacting region; LC3, microtubule-associated protein light chain 3; LIR, LC3-
interacting region; MAPK, mitogen-activated protein kinase; mTORC1, mammalian target of rapamycin complex 1; NF-jB,
nuclear factor kappa B; NRF2, nuclear factor erythroid 2-related factor 2; p62, p62/SQSTM1; PB1, Phox/Bem1p; RIP, receptor-
interacting protein; TBS, TRAF6-binding sequence; TRAF6, tumor necrosis factor receptor-associated factor 6; UBA, ubiquitin
associated; ZZ, ZZ-type zinc finger. Color images are available online.















































autophagy also provides essential nutrients for cellular sur-
vival in states of starvation. These classical functions of au-
tophagy have long been considered to constitute a
nonselective form of degradation, where adjacent cargo is
handled in bulk. However, there is increasing evidence that
some forms of autophagy are highly selective and well-
organized processes involving specifically marked cargo
recognized by the autophagic machinery (22). This selective
pathway requires adaptor proteins that can specifically bind
to cytosolic cargo and deliver them to autophagosomes.
The prototypical and most studied chaperone is p62 but
others include neighbor of BRCA1 gene (NBR1), optineurin
(OPTN), NDP52/CALCOCO2 (hereafter called NDP52,
nuclear dot protein 52 kDa/calcium-binding and coiled-coil
domain 2), toll-interacting protein (TOLLIP), BNIP3L/Nix,
FUN14 domain containing 1 (FUNDC1), and starch binding
domain 1 (STBD1). These receptors can recognize and sort
cytosolic cargo usually via an ubiquitin binding domain and
interact with the LC3/Atg8 family of autophagy proteins for
targeting to autophagosomes. Detailed understanding of this
selective autophagy requires uncovering how a particular or-
ganelle or protein is labeled, which specific adaptors recognize
the target, and what autophagy proteins act as their binding
partners. In the following discussion, we describe various
forms of selective autophagy and detail the known roles for
p62 in mediating their degradation. Furthermore, we correlate
how each of these p62-dependent processes contributes to the
progression or protection of metabolic diseases.
Aggrephagy
Aggrephagy, autophagic degradation of intracellular pro-
tein aggregates, is one of the earliest recognized forms of
selective autophagy, first described in neurodegenerative
diseases (113). Misfolded proteins originate from mistrans-
lation of defective ribosomal products, misfolding after
translation, abnormal protein modification, or mutations in
transcripts incurred by genomic damage. Under steady state
conditions, cells can defend against the toxicity of accumu-
lated misfolded proteins through chaperones involved in
monitoring protein folding, trafficking, and assisting in the
protein refolding, and preventing aggregation (41). Alter-
natively, chaperones can also aid in the degradation of mis-
folded proteins through the ubiquitin–proteasome system
(UPS) or the autophagy pathway by conjugating with E3
ubiquitin ligase, such as c-terminus of heat shock chaperone
70-interacting protein (CHIP) or Parkin (11, 75).
Ubiquitination is a post-translational modification that
plays an essential role in substrate recognition and degrada-
tion of proteins both by the UPS and selective autophagy (52,
84). The central feature of this ubiquitin tagging system uses
a series of enzymatic reactions involving the E1 ubiquitin
activating enzyme, E2 ubiquitin conjugating enzyme, and E3
ubiquitin protein ligase. Ubiquitin has seven internal lysine
residues (K6, K11, K27, K29, K33, K48, and K63) that are
used to conjugate to proteins as monomers or as polyubiquitin
chains. K48-linked polyubiquitin chains have been identified
as potent signals for protein targeting to protoesomes, whereas
K27- and K63-linked mono- or polyubiquitin chains have been
shown to target proteins for autophagic degradation. These
different patterns of ubiquitination offer the specificity needed
to initiate the next steps of autophagic degradation.
Recognition and delivery of ubiquitinated protein aggre-
gates to autophagosomes then require proteins containing
ubiquitin-binding domains. p62 is one of the most well
studied of these adaptors with the ability to recognize and
bind to ubiquitinated proteins through its UBA domain fol-
lowed by interaction with the core autophagic protein LC3
through the LIR domain (8, 50). Autophagy-linked FYVE
protein (ALFY, also known as WDFY3) has also been shown
to be a central scaffold protein in aggrephagy (12). ALFY is
essential for p62-dependent aggrephagy by interacting with
p62 as well as components of the autophagy initiation com-
plex (Atg5, Atg12) and phosphatidylinositol-3-phosphate, an
important lipid species regulating autophagosome membrane
formation (23) (Fig. 2A). Other adaptor proteins such as
histone deacetylases 6, a microtubule-associated deacetylase
with a ubiquitin-binding zinc-finger domain mediates ubi-
quitin binding, have also been shown to enhance transport of
ubiquitinated proteins into aggresomes, and promote fusion
of autophagosome with lysosome (44, 54); however, more
studies are needed to understand the relative importance of
p62 and these adaptors in aggrephagy.
Pexophagy
Peroxisomes are important metabolic organelles involved
in lipid metabolism by catabolizing long chain fatty acid b-
oxidation as well as reduction of reactive oxygen species
(ROS), specifically hydrogen peroxide. ROS produced as a
by-product of aerobic respiration is removed via peroxisomal
enzymes, a process essential for ameliorating the damaging
effects of ROS. Since impaired peroxisomes lead to accu-
mulation of ROS within the cell, dysfunctional peroxisomes
are cleared by the autophagy process called pexophagy. Work
thus far has again implicated the importance of ubiquitination
followed by recognition by the adaptor p62 and targeting to
autophagosomes (45). However, despite the importance of this
clearance mechanism in peroxisomal homeostasis, we only
have a rudimentary understanding of the components and
overall regulation of pexophagy in mammalian cells.
Recent studies have focused on peroxisomal matrix protein
receptor peroxin 5 (PEX5) as the ubiquitinated target in
pexophagy (45, 78). PEX5 can be shuttled between the per-
oxisomal membrane and the cytosol in a ubiquitin-dependent
manner (14). In response to ROS, ataxia-telangiectasia-
mutated signaling activates phosphorylation and mono-
ubiquitination of PEX5 at the peroxisomal membrane, upon
which it can be recognized by p62, leading to autophagosome
targeting and pexophagy (114). Furthermore, PEX1/PEX6
complexes, which form a single and heterohexameric Type 2
AAA-ATPase motor, appear to also play a role in pexophagy
by regulating shuttling of ubiquitinated PEX5 (25). The
ubiquitination of PEX5 is induced by the peroxisomal E3
ubiquitin ligase PEX2, particularly during amino acid star-
vation (92). There is also recent evidence that PEX5 might
not be the only target for initiating pexophagy. The ATP-
binding cassette transporter 70 kDa peroxisomal membrane
protein 70 (PMP70) is also ubiquitinated by PEX2 and might
be another key substrate for adaptor binding and autophago-
some targeting (92). Lastly, NBR1 has also been implicated as
an essential adaptor protein that can promote pexophagy (16).
Although independent of p62, the efficiency of NBR1 inter-
action with the peroxisome might also be enhanced by p62.















































The series of proteins implicated thus far in pexophagy are
summarized in Figure 2B. Overall, many unanswered ques-
tions remain in the process of pexophagy, including identi-
fication of the critical ubiquitination targets of PEX2,
uncovering the exact role of PMP70 ubiquitination, and de-
ciphering the relative importance of p62 and other adaptor
proteins in autophagosome targeting.
Mitophagy
Mitochondria play a central role in various metabolic
process, including production of the majority of cellular
ATP through oxidative phosphorylation and regulation of
the intrinsic pathway of apoptosis. In turn, mitochondrial
dysfunction is associated with excessive ROS production,
loss of control over apoptotic signals, and adverse effects on
metabolic homeostasis. Mitophagy is a critical mechanism by
which cells maintain metabolic homeostasis by eliminating
damaged or long-lived mitochondria via autophagic degra-
dation. Important proteins in mitophagy including the adap-
tor p62 have been identified, which we describe hereunder.
The phosphatase and tensin homolog (PTEN)-induced
putative kinase 1 (PINK1) and the E3 ubiquitin ligase Parkin
constitute the most studied mitophagy pathway responsible
for mitochondrial quality control (76, 66, 105). Although they
likely play important roles in a variety of diseases, both PINK1
and Parkin initially came to attention as Parkinson’s disease-
related genes (48, 98, 104). PINK1 requires depolarization of
FIG. 2. Selective autophagy related to p62. (A) Aggrephagy: CHIP and Parin are the major E3 ubiquitin ligase for
protein aggregates. p62, NBR1, and ALFY enhance transport of polyubiquitinated proteins into autophagosome, and
promote aggrephagy. (B) Pexophagy: The ubiquitination of PEX5 is mainly induced by the PEX2 E3 ubiquitin ligase. P62
and NBR1 mediate interaction of ubiquitinated peroxisomes and autophagosomes. (C) Mitophagy: PINK1 affects both of
ubiquitin phosphorylation and Parkin E3 ubiquitin ligase activation. The mitochondrial deubiquitinase USP30 and phos-
phatase PTEN-L antagonize PINK1/Parkin-mediated ubiqutination. p62, NDP52, and OPTN are adaptors implicated in
mitophagy. (D) (Left) Lysophagy: Galectins bind to exposed innermembrane glycosidase and recruit TRIM proteins.
Unknown ubiqutinated lysosomal proteins and TRIM interact with p62 directly to promote lysophagy. (Right) Lipopagy:
AUP1 recruits the Ube2g2 E2 ubiquitin conjugase. The LDs coated proteins PLIN2 and unknown ubiqutinated surface
proteins can bind with p62 for the progression of lipophagy. Also, Rab7 small GTPase directly recruits LDs and Rab10 to
the autophagosomal membrane by promoting interaction with the EHBP1 and EBDH2 complex on the autophagosome.
ALFY, autophagy-linked FYVE protein; CHIP, c-terminus of heat shock chaperone 70-interacting protein; LDs, lipid
droplets; NBR1, neighbor of BRCA gene 1; NDP52, nuclear dot protein 52kDa/calcium-binding and coiled-coil domain 2;
OPTN, optineurin; PEX, peroxin; PINK1, PTEN-induced putative kinase 1; PLIN2, Perilipin 2; PTEN, phosphatase and
tensin homolog; PTEN-L, PTEN-long.; USP, ubiquitin carboxyl-terminal hydrolase. Color images are available online.















































mitochondrial membrane potential for its inner mitochondrial
inner membrane import. In healthy conditions, PINK1 is
cleaved by mitochondrial intramembrane protease presenilin-
associated rhomboid like in the transmembrane segment and
subsequently released to the cytosol for proteasomal degra-
dation (38). However, mitochondrial damage and resultant
loss of mitochondrial membrane potential prevent PINK1
cytosolic export, leading to its accumulation on depolarized
mitochondria and phosphorylation of downstream targets such
as ubiquitin, mitofusin 2 (MFN2), and Parkin (51, 108). Parkin
not only assembles ubiquitin chains on the mitochondrial outer
membrane (MOM) but also acts to amplify the ‘‘phospho-
ubiquitin’’ mitophagy signal produced by PINK1 by recruiting
more Parkin to MOM (43). Phosphorylated MFN2 by PINK1
can also promote Parkin recruitment for generating ubiquitin
chains on MOM priming the mitochondria for mitophagy. It
should also be noted that this ubiquitination process can also
be reversed providing an early break on this process. Both
mitochondrial deubiquitinase ubiquitin carboxyl-terminal
hydrolase 30 (USP30) (7) and protein phosphatase PTEN
long (106) have been shown to antagonize PINK1/Parkin-
mediated ubiqutination through removal of phosphoubi-
quitin or ubiquitin chains from MOM.
Upon priming of mitochondria by ubiquitination, a large
body of evidence has implicated p62 as an essential chaper-
one mediating Parkin-dependent mitophagy (26, 79, 112).
p62 can bind the polyubiquitin chains of MOM through its
UBA domain and by interacting with Atg8/LC3 on autop-
hagosome through its LIR domain, and can target mito-
chondria for autophagic clearance. It should be noted that this
traditional model has been challenged recently, where, in lieu
of p62, PINK1 recruits two other adaptors OPTN and UDP52,
leading to recruitment of the critical autophagy Ser/Thr ki-
nase unc-51-like autophagy activating kinase (ULK1), and
activation of mitophagy. Importantly, this mechanism is also
independent of Parkin (57). These two competing mecha-
nisms are shown in Figure 2C. The relative importance of
each in various cell types and their relevance to metabolic
diseases remain unknown.
Lysophagy
P62-tagged cargoes are ultimately routed to the lysosome,
wherein an acidic environment and a diverse array of hydro-
lases mediate catabolism into basic metabolites. However,
lysosomes themselves are also vulnerable to damage, rupture,
and increases in membrane permeability often caused by in-
digestible crystalline material (83). These changes both disrupt
the normal degradative functions of the lysosome and release
hydrolases, which can damage other cellular components and
FIG. 3. Noncanonical domains of p62 involved in selective autophagy. Beside classical LIR and UBA domains
mediating selective autophagy, other domains of p62 also play important roles in autophagy as receptors or regulators. (1)
The N-terminal PB1 domain is a key component by functioning as an adaptor for the oligomerization of p62 and mediating
autophagy initiation in an LIR/UBA-independent manner. (2) The PB1 domain is also recognized and ubiquitinated by the
HECT E3 ubiquitin ligase NEDD4, thus enhancing selective autophagic degradation of inclusion bodies. Additional
interaction with the 19S proteasomal subunit PSMD4/Rpn10 accelerates delivery and clearance of ubiquitinated cargo to the
UPS. (3) The p62 UBA domain also recognizes the proteasome for autophagic degradation. (4) Interaction of PB1 and
MEKK3 activates a phosphorylation cascade leading to recruitment of TRAF-6 to p62 TB domain. TRAF-6 promotes
translocation of mTOR to lysosomes, its K63 ubiquitination, activation of mTOR signaling, and inhibition of autophagy. A
region between the p62 ZZ and TB domains (amino acids 167–230) also participates in lysosomal translocation and
activation of mTOR by binding with Raptor and RagC. mTOR, mammalian target of rapamycin; NEDD, neural precursor
cell expressed developmentally downregulated protein; UPS, ubiqitin proteasome system. Color images are available
online.















































initiate cell death. Lysophagy is the selective autophagic
degradation of damaged lysosomes and acts to limit these
adverse consequences (83). The proximal events mediating
lysophagy are thought to first include recognition of exposed
inner-membrane glycans by galectins and recruitment of
TRIM proteins, which serve as scaffolds to initiate a variety of
autophagy signaling cascades (46, 83). A number of TRIM
proteins are known to interact with p62 directly (46), and also
recruit E3 ubiquitin ligases to target sites of membrane dam-
age, (4) which may favor further ubiquitination, p62 binding,
and lysophagy. Indeed, the seminal reports characterizing ly-
sophagy observed ubiquitin and p62 colocalized at sites of
lysosomal membrane damage (31, 64). In addition, p62 is re-
quired for full recruitment of LC3 to damaged endolysosomes
(10). p62 has also been observed to be strongly localized to the
lysosome in contexts related to its signaling actions (discussed
in depth in subsequent sections). For example, p62 interacts
with mTOR and atypical PKCs at the lysosome and is a crucial
part of these signaling cascades (1, 65). The functional dif-
ferences in p62 action at the lysosome to either favor lyso-
phagy under conditions of lysosomal damage or serve these
types of signaling roles are likely determined by its specific
binding partners under either condition.
Lipophagy
Lipophagy, the selective degradation of lipid droplets
(LDs) via autophagy (115), was initially observed in hepa-
tocytes during starvation. Although starvation is thought to
induce global autophagy not overtly specific to any cargo, a
particular enrichment in autophagosomes containing only
LDs was observed, suggesting both the presence of a selec-
tive mechanism and that macroautophagy is a primary
mechanism of LDs delivery to the lysosome (99). Regardless
of the mode of lipid delivery, lysosomal hydrolysis of LD
cholesterol esters and triglycerides is mediated by lysosomal
FIG. 4. Roles for p62 in cardiometabolic diseases. The ability of p62 to mediate distinct autophagic processes impli-
cates it in a variety of cardiometabolic diseases. In atherosclerosis, p62-dependent aggrephagy and removal of inclusion
bodies ameliorates atherosclerosis by suppressing macrophage inflammasome activation, apoptosis, and necrotic core
formation. In the cardiac proteinopathy, p62-linked autophagy can mediate aggresome formation for removing the DRC-
linked proteins. In the liver, p62-dependent aggrephagy prevents accumulation of cytotoxic MDBs) and p62-dependent
mitophagy/pexophagy prevents accumulation of dysfunctional mitochondria and peroxisomes, which together ameliorate
the progression of fatty liver disease. In obesity, p62-dependent mitophagy modulates WAT adipogenesis, BAT thermo-
genesis, and the progression of obesity. DRC, desmin-related cardiomyopathy; MDB, Mallory–Denk body; WAT, white
adipose tissue. Color images are available online.















































acid lipase. Other major conceptual advances in the field
include recognition of the many interactions between au-
tophagy and cytosolic lipases such as adipose triglyceride
lipase, and the appreciation of microlipophagy as an impor-
tant mechanism of LDs delivery to the lysosome in some
contexts (93). In general, the characterization of the molec-
ular mechanisms initiating selective recruitment of autop-
hagosomes to LDs remains undercharacterized, and many
genetic or pharmacological manipulations reported to alter
lipophagy seem to act downstream of these putative initial
events. p62 is one of many potential molecular mediators
conferring selectivity for lipophagy and has recently been
observed at the LD in a novel screen for bona fide LD proteins
(5). One mechanism that could target LDs for lipophagy is
ubiquitination that is observed on many resident LD proteins
(20, 77, 100), although direct binding of these ubiquitin
moieties by p62 or other chaperones and relevance to lipo-
phagy are unconfirmed. Several earlier articles have assessed
the relevance of p62 to lipophagy. Wang et al. demonstrated
that p62 is required for full LC3 recruitment to LDs upon
ethanol-induced lipophagy, and that p62 silencing accord-
ingly resulted in triglyceride and cholesterol accumulation
(107). In another study, p62 was found to colocalize with LDs
and coimmunoprecipitate with the LD protein PLIN2 (Peri-
lipin 2) during lipophagy (55). It remains uncertain whether
p62 truly serves as a lipophagy chaperone in these settings as
p62 deficiency could impact lipolysis through many con-
nected signaling cascades. To test whether p62 at the LDs
was sufficient to induce lipophagy, Tatsumi et al. (101)
created a forced lipophagy system, wherein p62 was fused to
a LD localization domain from TIP47. Overexpression of this
fusion protein was found to reduce lipid content in an
autophagy-dependent manner and similar phenotypes were
not observed with simple p62 overexpression. The construct
also strongly colocalized with LC3/Lamp1, further suggest-
ing that p62 is capable of inducing lipophagy in this setting.
Additional studies might investigate whether p62 LIR do-
main deletion abrogates these phenotypes, and a great deal of
work is still required to discover the proximal events initi-
ating lipophagy, including how p62 or other chaperones are
recruited to the LD.
Noncanonical Domains of p62 Involved in Selective
Autophagy
Beside the prototypical p62 domains mediating selective
autophagy (i.e., the UBA’s association with ubiquitin-tagged
proteins and the LIR’s binding with the autophagy coat
protein LC3), other domains of p62 appear to also be in-
volved in various aspects of the initiation and regulation of
selective autophagy. These are depicted in Figure 3 and de-
scribed hereunder.
Role of the PB1 domain in clearance
of nonubiquitinated protein aggregates
The N-terminal PB1 domain plays a critical role in olig-
omerization of p62 by mediating interactions between basic
and acidic charge clusters through electrostatic forces (72). In
one study, oligomerization of p62 through PB1 promoted its
recruitment to endoplasmic reticulum-located autophago-
some formation sites in fibroblasts and was independent of
the interaction with the phagophore mediated by the LIR
domain, implying a different mechanism for autophagy ini-
tiation (35). Another study also showed the clearance of an
aggregation-prone isoform of signal transducer and activator
of transcription (STAT)5A to be dependent on interaction
with the p62 PB1 domain (109). Although aggregate for-
mation of this isoform is ubiquitination independent, the
PB1-mediated oligomerization of p62 may improve its in-
teraction with STAT5A aggregates and trigger their autop-
hagic clearance. Moreover, the HECT E3 ubiquitin ligase,
neural precursor cell expressed developmentally down-
regulated protein (NEDD)4, also interacts and ubiquitinates
the PB1 domain of p62, in turn, facilitating selective autop-
hagy and the degradation of inclusion bodies (60).
Involvement of the PB1 and UBA domains in the UPS
Autophagy and the UPS constitute two prominent and
distinct processes for the degradation of ubiquitin-labeled
intracellular cargo. Akin to its critical role in selective au-
tophagy, p62 also contributes to shuttling of ubiquitinated
proteins to proteasomes. However, instead of the LIR domain
of p62 for cargo delivery, ubiquitinated substrates are de-
livered via interaction of the PB1 domain with the 19S pro-
teasomal subunit PSMD4/Rpn10 (94).
p62 has also recently been implicated in targeting and re-
moval of proteasomes themselves, a mechanism that has long
been enigmatic. Recent study by Cohen-Kaplan et al. shows
that p62-mediated autophagy is likely the main degradation
pathway for the mammalian proteasome (13). Specifically,
amino acids starvation induces ubiquitination of select resi-
dues on the 19S proteasomal subunits, which are then rec-
ognized and interact with the p62 UBA domain for delivery
to the autophagosome. These data demonstrate p62’s unique
role as an adaptor linking these two degradation systems.
p62-mediated negative regulation of autophagy
by activation of mTOR signaling
Known as a critical regulator of intracellular metabolism
and cell growth, the mTOR predominantly inhibits autop-
hagy through the ULK1-FIP200-Atg13 complex. Interest-
ingly, unlike its classical role as an autophagy chaperone, p62
has also been paradoxically shown to negatively regulate
autophagy by activating mTOR. There are several proposed
mechanisms by which this occurs.
First, a region between the p62 ZZ and TB domains (amino
acids 167–230) is necessary for its interaction with raptor, a
main component of the mTORC1 complex. This interaction
appears to foster additional association of p62 with RagC,
activation of the regulator complex, docking of mTOR on the
lysosomal surface, and activation of downstream mTORC1
signaling (17). Aside from the proposed p62–raptor–RagC
interaction, Linares et al. have demonstrated another novel
mechanism of mTOR activation where the p62 TB and PB1
domains are involved (61). Interaction of MEKK3 with the
PB1 domain creates a molecular platform where amino acid
stimulation leads to successive activation of MEKK3, p38d,
and phosphorylation of T269 and S272 residues of p62. This
phosphorylation then recruits TRAF-6, a lysine 63 (K63) E3
ligase, to the p62 TB domain, which, in turn, promotes its
K63 ubiquitination as well as mTOR translocation to the
lysosomal surface and mTORC1 activation. The relationship















































between these two mechanisms of p62-mediated mTORC1
activation remains unclear.
Although the UBA and LIR domains of p62 are the most
studied and well-characterized contributors to selective au-
tophagy, the other p62 domains appear to also impact this
process in noncanonical ways including the potential of even
inhibiting autophagy. Such opposing effects of p62 in au-
tophagic degradation deserve continued investigation as they
reflect intricate feedback mechanisms that can play unique
roles in different cell types and during exposure to cellular
stress.
Crosstalk Between p62 and Other Chaperones
in Selective Autophagy
p62 is not the only adaptor/chaperone protein involved in
selective autophagy. As briefly listed previously, other p62-
like proteins serving this role include NBR1, NDP52, OPTN,
and STBD1. In fact, degradation of different cargos appears
to be preferentially mediated by distinct chaperones. In ad-
dition, interaction and cooperation between p62 and these
chaperones are not only important for the initiation and
processing of select autophagic substrates, but also provide
intricate regulatory mechanisms in the clearance of protein
aggregates and damaged organelles. We describe some of
these hereunder.
Neighbor of BRCA gene 1
NBR1 is a 966-amino acid protein that has domain orga-
nization similar to p62, including N-terminal PB1, ZZ zinc
finger, LIR, and C-terminal UBA domains (47). NBR1 has
been identified in intracellular inclusion bodies composed of
aggregated polyubiqitinated proteins. During aggrephagy,
NBR1 can bind p62 through its PB1 domain and promote
formation of the autophagic complex with other ATG family
members. Although NBR1 cannot dimerize by itself, it ap-
pears to still be able to mediate autophagic clearance of ag-
gregates in p62-deficient cells. For example, NBR1 can also
act as an autophagy adaptor for peroxisomes in a process
similar to that of p62. Deosaran et al. demonstrated that
several domains of NBR1 including an amphipathic a-helical
J domain along with UBA, LIR, coiled-coil domains are
necessary for NBR1-mediated pexophagy (16). Despite the
ability of NBR1 to promote pexophagy independent of p62,
its binding to p62 increases the efficiency of peroxisome
targeting to autophagosomes (47).
Nuclear dot protein 52 kDa and optineurin
NDP52 is another autophagy adaptor with reported roles
in mitophagy, aggrephagy, and xenophagy (102). In some
cases, it functions independently of p62 (e.g., NDP52 can
cooperate with OPTN in Pink1–Parkin-mediated mito-
phagy) (30). However, p62 can exert its influence on NDP52
transcript levels. NDP52 transcription is dependent on
NRF2, whose nuclear translocation is regulated by p62 via
its competitive binding with Keap1 (40). Thus, p62 can also
regulate selective autophagy indirectly by controlling ex-
pression of other chaperones.
Although less investigated, OPTN is another autophagy
adaptor with proposed p62-independent roles in mitophagy
(as already described) and xenophagy (particularly in clear-
ance of invading Salmonella) (110). In the context of p62,
OPTN ubiquitination by the tumor suppressor HACE1, an
ubiquitin ligase, promotes its interaction with p62, formation
of an autophagy adaptor complex, and acceleration of au-
tophagy flux (62).
TANK binding kinase 1
A further level of regulation worthy of mention is the effect
of phosphorylation on the efficiency of p62-mediated au-
tophagic clearance. The ability of p62 to associate with LC3/
ATG8 is increased upon phosphorylation of residues adjacent
to the LIR (68). Phosphorylation of the p62 UBA domain at
Ser-403 by the TBK1, a known p62-binding partner, im-
proves affinity of p62 for ubiquitin chains and enhances
aggrephagy (85). Furthermore, during Parkin-dependent
mitophagy, phosphorylated p62 by TBK1 during mitochon-
drial depolarization synergizes mitochondrial engulfment by
autophagosomes (67).
Regulation of p62
Both transcriptional and post-translational regulations of
p62 constitute important mechanisms by which autophagic
processing can be modulated. Several upstream signaling
pathways and their transcription factor effectors have been
implicated in upregulation of p62 transcripts, thus providing
enough of this chaperone to facilitate ongoing autophagy.
Transcription factor EB, known as the master regulator of the
autophagy-lysosomal biogenesis, is responsible for broad
transcriptional upregulation of the autophagic machinery
including p62 (21, 96, 96a). Under conditions of oxidative
stress where autophagy is concomitantly induced, the tran-
scription factor NRF2 directly induces p62 expression by
binding to conserved antioxidant-responsive elements in the
p62 promoter (15, 49). In a positive feedback cycle, p62 can
then stimulate NRF2 activity by interacting with and neu-
tralizing KEAP1, an inhibitor of NRF2 (36). In response to
other cellular stressors such as amino acid deficiency and
endoplasmic reticulum stress, activating transcription factor
4 plays an important role in transcriptional regulation of
autophagy genes including p62 by direct binding of their
promoters in conjunction with CCAAT/enhancer-binding
protein homologous protein (1, 24).
Besides modulation of transcript levels, p62 can also be
regulated via post-translational modification such as phos-
phorylation and ubiqutination. Phosphorylation of serine 403
(S403) located in the UBA domain of p62 by TBK1 and CK2
promotes its binding affinity for ubiquitinated cargos des-
tined for autophagic degradation (67, 68, 85). Phosphoryla-
tion of serine 351 (S351) at the p62 KIR domain enhances its
affinity for KEAP1, which not only promotes the autophagic
removal of ubiquitinated cargo but also liberates NRF2 to
transcriptionally upregulate p62 as already discussed (32).
Ubiquitination of lysine 420 (K420) located in the p62 UBA
domain by Keap1/Cullin3 also enhances autophagic degra-
dation (59), whereas ubiquitination of lysine 7 (K7) in the p62
PB domain by the E3 ubiquitin ligase TRIM21 interferes with
p62 oligomerization and cargo sequestration (81). Although
these findings suggest the importance of nuanced p62 regu-
lation in autophagy, further study in needed to delineate
whether this regulation differs in the various types of selec-
tive autophagy.















































Roles for p62 in Cardiometabolic Disease
Mutations in a variety of p62 domains have long been
known to underlie autosomal dominant diseases, such as
frontotemporal dementia, amyotrophic lateral sclerosis, Pa-
get’s disease, and distal myopathy. Although variants in p62
have not yet been uncovered in genome-wide association
studies of common cardiometabolic diseases, experimental
evidence clearly implicates p62 as a major player in athero-
sclerosis, cardiac proteinopathies, nonalcoholic fatty liver
disease, obesity, and type 2 diabetes (Fig. 4).
In the atherosclerotic plaque, appropriate function of the
autophagy–lysosome pathway in crucial cell types such as
macrophages is essential for limiting inflammation, promot-
ing cell survival, and appropriately handling lipids. Several
studies provide strong evidence that p62-linked selective
autophagy is particularly relevant to atherosclerosis in this
regard. As discussed, p62 is known to tag ubiquitinated pro-
tein aggregates, serve as a link between ubiquitinated targets
and autophagic machinery, and, therefore, accumulate as a
consequence of dysfunctional autophagy (9). Atherosclerotic
plaques are no exception and both human and murine samples
feature marked p62 accumulation (21, 95, 96). Furthermore,
macrophage-specific autophagy deficiency worsens athero-
sclerosis through accumulation of a variety of selective au-
tophagy cargo related to p62. For example, lipophagy is
essential for targeting macrophage LDs for lysosomal hy-
drolysis and cholesterol efflux (37, 80), and it would be
worthwhile to assess the role of p62 in this process. Another
key phenotype of macrophage-specific autophagy deficiency
is inflammasome activation, particularly in the setting of
cholesterol crystal accumulation (86). Mitochondrial dys-
function and inflammation in this setting may be downstream
of defective aggrephagy, mitophagy, and lysophagy.
Evidence from our laboratory characterizing p62-deficient
mouse models further supports the important roles of p62 in
atherosclerosis. Mice deficient in p62 have increased ath-
erosclerotic plaque burden with elevated macrophage in-
flammation, macrophage apoptosis, necrotic core formation,
and plaque complexity (95). Mechanistically, p62-linked
protein aggregation and aggrephagy limit inflammasome
activation in a manner that is dependent on ubiquitin binding
and that is not impacted by NRF2, ERK, p38, or NF-jB in-
hibition (83, 101). Overall, p62’s role in selective autophagy
seems to be a primary mechanism of atheroprotection, but
more specific investigation of the impacts of deficiency on
specific cargoes such as mitochondria and LDs is warranted.
There is also emerging evidence for the role of p62 and
selective autophagy pathways in the spectrum of cardiac
diseases known as cardiac proteinopathies. Desmin-related
cardiomyopathy (DRC), which represents a prototypical
cardiac proteinopathy, is characterized by an accumulation
of misfolded proteins and protein aggregates in cardio-
myocytes resulting in cytotoxicity (88). Recent studies have
shown that p62 expression is significantly increased in the
myocardium of a DRC mouse model in conjunction with
accumulation of protein aggregates (6). Cardiomyocyte
p62 mediates aggresome formation as well as activation of
autophagy of the DRC-linked misfolded proteins (116).
Although the precise molecular mechanisms of the disposal
of these aggregates in cardiomyocytes remain undefined,
such initial observations suggest that impairment of p62-
dependent aggrephagy plays a prominent role in the path-
ogenesis of cardiac proteinopathies.
In the context of liver disease, Singh et al. were the first to
suggest that autophagy plays a pivotal role in hepatocytes to
deliver LDs to lysosomes for hydrolysis and provided some of
the earliest experimental evidence for lipophagy in vivo. In-
hibition of lipophagy led to decreased triglyceride hydrolysis
and fatty acid b-oxidation, which resulted in LD accumulation
in cultured hepatocytes and lipid-laden livers in mice (99).
This study also highlighted that dysfunctional lipophagy in
hepatocytes could contribute to human liver disease caused by
excessive accumulation of lipid, such as nonalcoholic fatty
liver disease (NAFLD). Also, recent studies have found that
progressive insulin resistance and oxidative stress in fatty
livers can instigate autophagy dysfunction, increased p62
levels, and massive accumulation of mitochondria and
peroxisome in liver (28). Reductions in this p62-dependent
selective autophagy lead to deleterious accumulation of cy-
totoxic organelles and exacerbate liver injury.
Accumulation of protein inclusion called Mallory–Denk
bodies (MDBs) or Mallory’s hyaline has also been described
in livers of patients with alcoholic liver disease and NAFLD
(53). Dysfunction in p62-dependent aggrephagy in hepato-
cytes appears to be a major cause of these accumulated in-
clusion bodies. Interestingly, p62-laden MDBs are not a
phenomenon exclusive to hepatosteatosis as it has also been
described in hepatocellular carcinoma among other cancers
(65, 103). A related consequence of this p62 buildup is in-
creased interactions with Keap1, persistent activation of
NRF2, and progression of hepatocellular adenomas (33).
Thus, impaired hepatic autophagy with resulting accumula-
tion of cytotoxic organelles and protein aggregates creates
multiple independent insults to the liver.
Among the most striking phenotypes of whole-body mu-
rine p62 deficiency is the clear development of mature-onset
obesity and associated insulin resistance (87). Enhanced
ERK1 activity in this model has been proposed as key me-
diator of these phenotypes. Impressively, ERK1 deficiency
alone has minimal impact on energy expenditure, obesity,
adipogenesis, or insulin resistance, but can almost entirely
normalize the abnormalities in these phenotypes observed
with p62 deficiency (58). Another aspect of p62 function
relevant to obesity is linked to signaling through the p38-
MAPK pathway, an important input to transcriptional control
of brown/beige adipose tissue thermogenesis. p62 deficiency
is associated with decreased UCP-1 and PGC-1a levels in
BAT and deficiency impairs mitochondrial gene expression
and functional thermogenesis in a cell-autonomous manner.
The impacts of p62 deficiency on impaired mitophagy and
lipophagy in this context deserves future attention, as defects
in either pathway could also contribute to this phenotype.
Whether these phenotypes of p62-deficient mice are entirely
related to action at the level of adipocytes is also unclear. On
one hand, aP2-Cre mediated tissue-specific knockout of p62
recapitulated key phenotypes of whole body deficiency in-
cluding obesity, glucose intolerance, and insulin resistance,
same with p62 whole body deficient mice (74). However,
aP2-Cre has now been shown multiple times to elicit re-
combination in several nonadipocyte tissues including neu-
rons, and neuron-specific p62-deficient mice (Nestin-cre/
p62-floxed mice) also display an obese phenotype (29). This
model displayed leptin resistance linked to defective STAT3















































activity, hyperphagia, and mature-onset obesity in brain-
specific p62 deficiency.
Concluding Remarks/Future Directions
There is increasing evidence that p62 is a major adaptor
protein linking aggregated proteins and damaged cellular
organelles to autophagic degradation. A number of selec-
tive autophagy processes including aggrephagy, mito-
phagy, pexophagy, lysophagy, and lipophagy use p62 as the
critical chaperone for cargo selection. Disruptions in the
ability of p62 to deliver specific cargo for degradation, it can
lead disruptions in the homeostasis of cellular signaling and
metabolic pathways with important ramifications on a myriad
of cardiovascular and cardiometabolic diseases. Although the
intricacies of these pathways have not been fully elucidated in
relevant organ systems, our progressive understanding of the
involved processes will clarify not only disease pathogenesis
but also provide a basis for the development of new therapies
that harness autophagy and cellular degradation pathways.
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Abbreviations Used
ALFY¼ autophagy-linked FYVE protein
aPKC¼ atypical protein kinase C
BAT¼ brown adipose tissue
CHIP¼ c-terminus of heat shock chaperone
70-interacting protein
CK2¼ casein kinase 2
DRC¼ desmin-related cardiomyopathy
ERK1¼ extracellular signal-regulated kinase 1











mTOR¼mammalian target of rapamycin
mTORC1¼mammalian target of rapamycin
complex 1
NAFLD¼ nonalcoholic fatty liver disease
NBR1¼ neighbor of BRCA gene 1
NDP52/CALCOCO2¼ nuclear dot protein 52kDa/
calcium-binding and coiled-coil
domain 2
NEDD¼ neural precursor cell expressed
developmentally downregulated
protein
NF-jB¼ nuclear factor kappa B







PINK1¼ PTEN-induced putative kinase 1
PLIN2¼ Perilipin 2
PMP70¼ peroxisomal membrane protein 70
PTEN¼ phosphatase and tensin homolog
RIP1¼ receptor-interacting protein 1
ROS¼ reactive oxygen species
STAT¼ signal transducer and activator
of transcription
STBD1¼ starch binding domain 1
TBK1¼TANK binding kinase 1
TBS¼TRAF6-binding sequence
TRAF6¼ tumor necrosis factor
receptor-associated factor 6
UBA¼ ubiquitin associated
UCP1¼ uncoupling protein 1
ULK¼Unc-51 like autophagy activating
kinase
UPS¼ ubiquitin-proteasome system
USP¼ ubiquitin carboxyl-terminal hydrolase
ZZ¼ZZ-type zinc finger
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